UnknownNot Applicable

Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes

Egypt60 participantsStarted 2021-12-01

Plain-language summary

Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Study group: Singleton pregnancies complicated with diabetes undergoing pre-labour CS at gestational age (37+0 to 40+0). These will be divided into 3 groups according to the type of disease either Gestational diabetes (Group A), pregestational diabetes type 1 (Group B) or type 2 (Group C). 2-Control group: Singleton pregnancies undergoing elective pre-labour CS at gestational age (37+0 to 40+0) that are otherwise healthy

What they're measuring

Telocytes

Timeframe: Telocytes will be assessed in placental and umbilical cord tissues fixed immediately after delivery.

Trial details

NCT IDNCT05305326

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

Contact for this trial

Amr O Abdelkareem, MD

00201001259562 amr.oth@med.sohag.edu.eg

View on ClinicalTrials.gov More Diabetes in Pregnancy trials